Explore
Trendline
BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market
BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market
Read More
Trendline
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Read More
Trendline
Myomo Reports Q1 2026 Financial Results with Increased Revenue and Narrowed Loss
Myomo Reports Q1 2026 Financial Results with Increased Revenue and Narrowed Loss
Read More
Trendline
Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance
Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance
Read More
Trendline
Tandem Diabetes Care Reports Strong First Quarter 2026 Financial Results
Tandem Diabetes Care Reports Strong First Quarter 2026 Financial Results
Read More
Trendline
EPAM Systems Reports Strong Q1 2026 Financial Results Amid AI Transformation
EPAM Systems Reports Strong Q1 2026 Financial Results Amid AI Transformation
Read More
Trendline
OUTFRONT Media Reports Strong Q1 2026 Financial Results with Increased Revenue and Income
OUTFRONT Media Reports Strong Q1 2026 Financial Results with Increased Revenue and Income
Read More
Trendline
OUTFRONT Media Reports Strong Q1 2026 Financial Results with Increased Revenues and Earnings
OUTFRONT Media Reports Strong Q1 2026 Financial Results with Increased Revenues and Earnings
Read More
Trendline
Myomo Reports Increased Revenue and Narrowed Losses in Q1 2026
Myomo Reports Increased Revenue and Narrowed Losses in Q1 2026
Read More
Trendline
Nature's Sunshine Reports $5.1 Million Net Income in Q1, Projects Strong Full-Year Revenue
Nature's Sunshine Reports $5.1 Million Net Income in Q1, Projects Strong Full-Year Revenue
Read More
Trendline
Tandem Diabetes Care Reports Record Q1 2026 Financial Results and Strategic Advances
Tandem Diabetes Care Reports Record Q1 2026 Financial Results and Strategic Advances
Read More
Trendline
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Read More